Company Filing History:
14 out of 30 
4 out of 10 
3 out of 3 
Years Active: 1990-2020
Title: The Innovative Contributions of Selvaraj A Naicker in Immunomodulation
Introduction: Selvaraj A Naicker, a notable inventor based in Edmonton, CA, has made significant advancements in the field of biochemistry, particularly focusing on immunomodulating agents. With an impressive portfolio of 25 patents, his work largely revolves around cyclosporine analogues, showcasing his dedication to improving therapeutic efficacy and reducing toxicity.
Latest Patents: Among his recent inventions is a groundbreaking patent for "cyclosporine analogue mixtures and their use as immunomodulating agents." This invention focuses on isomeric mixtures of cyclosporine analogues that closely resemble cyclosporine A. The patent highlights that these mixtures exhibit enhanced effectiveness and lower toxicity compared to both individual isomers and existing cyclosporine derivatives. Specifically, it delves into the properties of cis and trans-isomers of cyclosporin A analogs, known as ISA247, and their derivatives. Remarkably, these mixtures demonstrate a potent combination of efficacy and reduced side effects, marking a substantial advancement in therapeutic options for immunomodulation.
Career Highlights: Selvaraj A Naicker has held influential roles in reputable organizations such as Isotechnika Inc. and Quest Pharmatech, Inc. His contributions have been pivotal in the development of innovative biopharmaceuticals targeting various immune responses. Through his research and application of stereoselective synthesis methods, he has paved the way for more effective treatments.
Collaborations: Throughout his career, Naicker has collaborated with esteemed colleagues, including Randall W. Yatscoff and Robert T. Foster. These collaborations have fostered a productive environment for research and development, contributing to the substantial body of work that Naicker is known for today.
Conclusion: Selvaraj A Naicker stands out as a leading inventor in the field of immunomodulation with a focus on cyclosporine analogues. His latest patents not only reflect his innovative approach but also emphasize the importance of collaboration in advancing medical science. With a total of 25 patents to his name, his contributions continue to influence the landscape of therapeutic interventions, underscoring the vital role of inventors in the health and medical sectors.